Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Johnson

Showing results (151-160 of 203) with videos related to

Pageof 21
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 3, 2025
Proteomic subtyping of Alzheimer's disease CSF links blood-brain barrier dysfunction to reduced levels of tau and synaptic biomarkersMadison C Bangs, Joshna Gadhavi, E Kathleen Carter, et al.
Nature Medicine|July 15, 2025
APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseasesArtur Shvetcov, Erik C B Johnson, Laura M Winchester, et al.
Science Advances|October 22, 2020
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's diseaseLenora Higginbotham, Lingyan Ping, Eric B Dammer, et al.
Molecular Neurodegeneration|October 8, 2024
Heparin-enriched plasma proteome is significantly altered in Alzheimer's diseaseQi Guo, Lingyan Ping, Eric B Dammer, et al.
Scientific Data|December 4, 2021
Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysisHazal Haytural, Rui Benfeitas, Sophia Schedin-Weiss, et al.
Science Translational Medicine|September 6, 2023
A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's diseaseRafi Haque, Caroline M Watson, Jiaqi Liu, et al.
Neurobiology of Disease|September 9, 2023
Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairmentLenora Higginbotham, E Kathleen Carter, Eric B Dammer, et al.
Seminars in Neurology|November 28, 2025
Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related DementiasAndrew G Breithaupt, Alice Tang, Emily W Paolillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2024
Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluidAleksandra M Wojtas, Eric B Dammer, Qi Guo, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Proteomic Changes in the Human Cerebrovasculature in Alzheimer's Disease and Related Tauopathies Linked to Peripheral Biomarkers in Plasma and Cerebrospinal FluidAleksandra M Wojtas, Eric B Dammer, Qi Guo, et al.
Pageof 21

Showing results (151-160 of 203) with videos related to

Sort By:
Pageof 21
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 3, 2025
Proteomic subtyping of Alzheimer's disease CSF links blood-brain barrier dysfunction to reduced levels of tau and synaptic biomarkersMadison C Bangs, Joshna Gadhavi, E Kathleen Carter, et al.
Nature Medicine|July 15, 2025
APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseasesArtur Shvetcov, Erik C B Johnson, Laura M Winchester, et al.
Science Advances|October 22, 2020
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's diseaseLenora Higginbotham, Lingyan Ping, Eric B Dammer, et al.
Molecular Neurodegeneration|October 8, 2024
Heparin-enriched plasma proteome is significantly altered in Alzheimer's diseaseQi Guo, Lingyan Ping, Eric B Dammer, et al.
Scientific Data|December 4, 2021
Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysisHazal Haytural, Rui Benfeitas, Sophia Schedin-Weiss, et al.
Science Translational Medicine|September 6, 2023
A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's diseaseRafi Haque, Caroline M Watson, Jiaqi Liu, et al.
Neurobiology of Disease|September 9, 2023
Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairmentLenora Higginbotham, E Kathleen Carter, Eric B Dammer, et al.
Seminars in Neurology|November 28, 2025
Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related DementiasAndrew G Breithaupt, Alice Tang, Emily W Paolillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2024
Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluidAleksandra M Wojtas, Eric B Dammer, Qi Guo, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Proteomic Changes in the Human Cerebrovasculature in Alzheimer's Disease and Related Tauopathies Linked to Peripheral Biomarkers in Plasma and Cerebrospinal FluidAleksandra M Wojtas, Eric B Dammer, Qi Guo, et al.
Pageof 21